HRT Financial’s Oculis Holding OCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-148,021
Closed -$3.94M 5016
2026
Q1
$3.94M Buy
148,021
+104,107
+237% +$2.76M 0.01% 1152
2025
Q4
$876K Buy
+43,914
New +$878K ﹤0.01% 1800
2023
Q2
Sell
-24,609
Closed -$178K 3013
2023
Q1
$178K Buy
+24,609
New +$206K ﹤0.01% 1948

Other funds holding OCS

HRT Financial's OCS Position: Q2 2026 in Review

HRT Financial sold out of Oculis Holding (OCS) in Q2 2026, closing a stake of 148,021 shares — an estimated $3.94M sold.

HRT Financial first reported a position in OCS in Q1 2023 and held it in 3 quarters. The position peaked at $3.94M in Q1 2026. 59 funds tracked by Wall St. Rank hold OCS as of Q2 2026.

  • HRT Financial reported no remaining Oculis Holding position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 148,021 Oculis Holding shares in Q2 2026, an estimated $3.94M.
  • HRT Financial first reported a position in Oculis Holding in Q1 2023 and held it in 3 quarters.
  • HRT Financial's Oculis Holding position peaked at $3.94M in Q1 2026.
  • 59 funds tracked by Wall St. Rank held Oculis Holding as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.